Idera Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 45   

Articles published

IDRA 2.32 -0.03 (-1.28%)
price chart
Idera Pharmaceuticals Expands Pipeline by Initiating Clinical Development of ...
CAMBRIDGE, Mass., Oct. 14, 2014 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (Nasdaq:IDRA), a clinical-stage biopharmaceutical company developing nucleic acid therapeutics for patients with cancer and rare diseases, today announced it has ...
Related articles »  
Idera Pharmaceuticals Inc. (IDRA) Jumps 5.10% on October 13
Idera Pharmaceuticals Inc. (IDRA) was among the biggest gainers on the Russell 2000 for October 13 as the stock popped 5.10% to $2.06, representing a gain of $0.10 per share.
Top News: Citigroup Inc. (NYSE:C), Idera Pharmaceuticals, Inc. (NASDAQ:IDRA ...
Idera Pharmaceuticals Inc (NASDAQ:IDRA) announced the net loss of $8.4 million in 2Q2014 comparable to the net loss of $5.6 million a year ago.
Related articles »  
Trending Stocks: Idera Pharmaceuticals (NASDAQ:IDRA), Juniper Networks ...
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company developing nucleic acid therapeutics for patients with cancer and rare diseases announced it has advanced IMO-9200 into Phase 1 clinical development following ...
SunPower (NASDAQ:SPWR) in Imported Declaration with Idera ...  The Cinema Post
Related articles »  
Investor's Alert- Capitol Federal Financial, Inc. (CFFN), Idera ...
Las Vegas, NV �October 17, 2014� (TechSonian) �Capitol Federal Financial, Inc.(NASDAQ:CFFN) posted that itis the holding company for Capitol Federal Savings Bank. Capitol Federal Savings Bank is a federally charted stock savings bank. The Bank has ...
Related articles »  
Stocks Trending Alert - Idera Pharmaceuticals, (NASDAQ:IDRA), FelCor Lodging ...
Idera Pharmaceuticals Inc(NASDAQ:IDRA) closed at $2.40 in the last trading session with the overall traded volume of 759,425 shares, versus the average volume of 822,998 shares.
Related articles »  
Health Stock in Focus: Lakeland Industries, Inc. (NASDAQ:LAKE), BioCryst ...
Idera Pharmaceuticals Inc (NASDAQ:IDRA) a clinical-stage biopharmaceutical firm declared it has advanced IMO-9200 into Phase 1 clinical development subsequent acceptance of an Investigational New Drug submission by the United State Food and Drug ...
Momentum Stocks: NorthStar Realty Finance Corp. (NYSE:NRF), Idera ...
On last trading day Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) moved down -3.30% to close at $2.64. IDRA is -61.57% away from its 52 week high and is moving 74.83% ahead of its 52 week low.
Buzzing Stocks: China Telecom Corporation Limited (ADR)(CHA) Arrowhead ...
Bruce Given, M.D., the CEO, will attend the conference on behalf of Arrowhead. The conference is scheduled on September 26, 2014. Investors can access the live webcast on the official website.
Stocks on Trader's Radar �Globus Medical Inc (GMED), Northern Oil & Gas, Inc ...
Las Vegas, NV - September 16, 2014 - (TechSonian) �Globus Medical Inc (GMED) a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders.
Related articles »